Illegal, Unpleasant, Unpatented and Potentially Life-Saving: the Ibogaine Question
On April 18, 2026, President Trump signed Executive Order 14401, which directs federal agencies to accelerate research into psychedelic medications for the treatment of serious mental illness, including substance use disorder. One of the most prominent substances mentioned in this EO is the alkaloid ibogaine.